Neuronetics, Inc. Other Current Liabilities
Neuronetics, Inc. (STIM) had Other Current Liabilities of $425.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Other Liabilities, Current $425.00K.
- 2026-03-31: Other Liabilities, Current $751.00K.
- 2025-12-31: Other Liabilities, Current $652.00K.
- 2025-09-30: Other Liabilities, Current $376.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $425.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $751.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $652.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $376.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $285.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $346.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $605.00K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $1.95M 8-K/A · filed 2025-02-06 | $1.05M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $877.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $5.73M 8-K/A · filed 2025-02-06 | $1.05M 10-K · filed 2024-03-08 |
| 2023-09-30 | $853.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $759.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $701.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $800.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $933.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $994.00K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $869.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $980.00K 10-K · filed 2023-03-07 | |
| 2021-09-30 | $509.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $428.00K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $370.00K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $531.00K 10-K · filed 2022-03-08 | $604.00K 10-K · filed 2021-03-02 |
| 2020-09-30 | $434.00K 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $344.00K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $434.00K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $687.00K 10-K · filed 2021-03-02 | $560.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | $612.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $466.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $509.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $493.00K 10-K · filed 2020-03-03 | |
| 2018-09-30 | $528.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $710.00K 10-Q · filed 2018-08-14 | |
| 2017-12-31 | $388.00K 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |